The present invention provides compounds of Formula (I):
##STR1##
wherein: R1, R2, R3, R4, R5,
R6 R7, R8, n, m, and X have any of the values
defined in the specification, as well as pharmaceutical compositions comprising
the compounds. The invention also provides therapeutic methods as well as processes
and intermediates useful for preparing compounds of Formula (I). The compounds
are 5-HT ligands and are useful for treating diseases wherein modulation of 5-HT
activity is desired.
